Cefoxitin
CEFOXITIN FOR INJECTION, USP
Approved
Approval ID
6a4a2afa-4f00-41d4-bd6d-baa0a95f6929
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 8, 2021
Manufacturers
FDA
Hikma Pharmaceuticals USA Inc.
DUNS: 001230762
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Cefoxitin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0143-9876
Application NumberANDA065239
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefoxitin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 8, 2021
FDA Product Classification
INGREDIENTS (1)
CEFOXITIN SODIUMActive
Quantity: 10 g in 1 1
Code: Q68050H03T
Classification: ACTIM